Lampalizumab (Anti-Complement Factor D)
Lampalizumab (Anti-Complement Factor D) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research. MW: 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2535 |
Sku # | A2535-1mg*5 |
Pricing | 1mg*5, $1690.00 |